Changes of gut microbiota after Helicobacter pylori eradication: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029940

Enrollment

Unknown

Registered

2020-02-17

Start date

2020-04-02

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobater pylori

Interventions

HDDT group:high-dose dual therapy

BQT group:bismuth quadruple therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with at least two positive tests among histology, culture, rapid urease test, and urea breath test. Asymptomatic patients with a single positive urea breath test were also eligible.

Exclusion criteria

Exclusion criteria: Under 18 years old, history of gastrectomy, previous eradication therapy for H pylori, contraindication or previous allergic reactions to the study drugs, severe concurrent diseases or malignancy, pregnant or lactating women, and patients who could not give informed consent.

Design outcomes

Primary

Measure	Time frame
gut microbiota;	—

Countries

China

Contacts

Public ContactCaiping Gao

Sichuan Academy of Medical Sciences (Sichuan people's Hospital)

gaocaip@126.com+86 28-87394207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026